Skip to main content

8 Result(s)

within Meijuan Huang Remove this filter Medicine & Public Health Remove this filter English Remove this filter

and

  1. Article

    Open Access

    First-line treatment of driver gene-negative metastatic lung adenocarcinoma with malignant pleural effusion: Should chemotherapy be combined with an immune checkpoint inhibitor or bevacizumab?

    Patients with metastatic lung adenocarcinoma (MLA) and malignant pleural effusion (MPE) without driver gene mutations have a poor prognosis. None of the standard treatment strategies is recommended for such pa...

    Yuanyuan Zhao, Ting Mei, Feifei Na, **aoman Tian, Rui Ao… in Investigational New Drugs (2024)

    Download PDF (1718 KB) View Article

  2. No Access

    Article

    Stereotactic body radiotherapy to the primary lung lesion improves the survival of the selected patients with non-oligometastatic NSCLC harboring EGFR activating mutation with first-line EGFR-TKIs: a real-world study

    This study aimed to explore the clinical value of SBRT for primary lung lesions of EGFR-mutant NSCLC patients with non-oligometastatic disease during first-line EGFR-TKI treatment.

    Hao Wei, **aojuan Zhou, Hui Yang… in Journal of Cancer Research and Clinical On… (2022)

  3. Article

    Open Access

    A phase I study of the tyrosine kinase inhibitor anlotinib combined with platinum/pemetrexed-based chemotherapy in untreated nonsquamous non-small-cell lung cancer

    Background. Anlotinib hydrochloride is an oral small molecule inhibitor of multiple tyrosine kinases, and it has been approved as a third-line therapy for patients with advanced non-small-cell lung cancer (NSCLC)...

    Meijuan Huang, Yongmei Liu, Min Yu, Yanying Li, Yan Zhang… in Investigational New Drugs (2022)

    Download PDF (1170 KB) View Article

  4. No Access

    Article

    A phase I dose-reduction study of apatinib combined with pemetrexed and carboplatin in untreated EGFR and ALK negative stage IV non-squamous NSCLC

    Objective Apatinib is an oral small molecule anti-angiogenic drug. This phase I study aimed to establish the feasible dose of apatinib in combination with pemetrexed plus carboplatin as first-line therapy for epi...

    Meijuan Huang, Youling Gong, Jiang Zhu, Yi Qin, Feng Peng… in Investigational New Drugs (2020)

  5. No Access

    Article

    Monitoring the estimated glomerular filtration rate (eGFR) in patients with small-cell lung cancer during chemotherapy: equations based on serum creatinine or cystatin C?

    This study compared the differences between the estimated glomerular filtration rate (eGFR) calculated by several equations based on serum creatinine (Scr) and cystatin C (CysC) concentrations for monitoring r...

    Xue Tian, **nxing Zhang, Min Yu, You Lu… in International Journal of Clinical Oncology (2018)

  6. No Access

    Article

    Primary tracheal adenoid cystic carcinoma: adjuvant treatment outcome

    Adenoid cystic carcinoma (ACC) is the second most common tracheal tumor, but its optimal treatment strategy is still controversial.

    Furong Chen, Meijuan Huang, Yong Xu, Tao Li… in International Journal of Clinical Oncology (2015)

  7. No Access

    Article

    Phase II evaluation of nedaplatin and paclitaxel in patients with metastatic esophageal carcinoma

    To evaluate the efficiency and toxicities of nedaplatin and paclitaxel in patients with metastatic carcinoma of the esophagus.

    Youling Gong, Li Ren, Lin Zhou, Jiang Zhu… in Cancer Chemotherapy and Pharmacology (2009)

  8. No Access

    Article

    Expression of Neuropilin-1 Gene in Bone Marrow Stromal Cells from Patients with Myeloid Leukemia and Normal Individuals

    Objective: To investigate the expression of neuropilin-1 (NP-1) gene in bone marrow stromal cells (BMSCs) from myeloid leukemia (AML and CML) and normal individuals. Methods: Mononuclear cells were isolated fr...

    Ying SU, Zhen WANG, **uli WU, Meijuan HUANG… in The Chinese-German Journal of Clinical Onc… (2005)